Science Explorer Back to mapMap

Most cited papers from Repligen (United States)

What are the most cited papers from Repligen (United States)?

The most cited paper from Repligen (United States) is "Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation" (Gordon James Freeman, John G. Gribben, Vassiliki A. Boussiotis et al., 1993), with 920 citations. Next come "Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides" (708) and "Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant" (655).

Showing 50 of 60 papers. Every paper with more than 122 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation Gordon James Freeman, John G. Gribben, Vassiliki A. Boussiotis et al. · Science 5 Nov 1993 920
2 Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides Theodore E. Maione, Gary S. Gray, Joan Petro et al. · Science 5 Jan 1990 708
3 Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant Gregory J. LaRosa, Joseph P. Davide, Kent J. Weinhold et al. · Science 24 Aug 1990 655
4 Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. J R Rusche, Kashi Javaherian, Charlene B. McDanal et al. · Proceedings of the National Academy of Sciences Open access May 1988 624
5 Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Kashi Javaherian, A J Langlois, Charlene B. McDanal et al. · Proceedings of the National Academy of Sciences Open access Sep 1989 620
6 Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis Scott L. Gottlieb, Patricia Gilleaudeau, Ray A. Johnson et al. · Nature Medicine May 1995 616
7 Validation of the general purpose QUANTA ®3.2/CHARMm® force field Frank A. Momany, Rebecca J. Rone · Journal of Computational Chemistry Sep 1992 581
8 B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4 Gordon James Freeman, Vassiliki A. Boussiotis, Anukanth Anumanthan et al. · Immunity Open access May 1995 566
9 HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation Susan C. McQuown, Ruth M. Barrett, Dina P. Matheos et al. · Journal of Neuroscience Open access 12 Jan 2011 514
10 Production of multiple ligninases by Phanerochaete chrysosporium: effect of selected growth conditions and use of a mutant strain T. Kent Kirk, Suki C. Croan, Ming Tien et al. · Enzyme and Microbial Technology 1986 504
11 CERTS Microgrid Laboratory Test Bed Robert H. Lasseter, Joseph H. Eto, Benjamin L. Schenkman et al. · IEEE Transactions on Power Delivery Open access 29 Dec 2010 477
12 Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs Hidemi Takahashi, Toshiyuki Takeshfta, Brør Morein et al. · Nature 26 Apr 1990 476
13 Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody Emilio A. Emini, William A. Schleif, Jack H. Nunberg et al. · Nature Feb 1992 476
14 HIV-1 structural gene expression requires binding of the rev trans-activator to its RNA target sequence Michael H. Malim, Laurence S. Tiley, David F. McCarn et al. · Cell Feb 1990 444
15 Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma Assaf Magen et al. · Nature Medicine Open access Jun 2023 429
16 HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner Melissa Malvaez, Susan C. McQuown, George A. Rogge et al. · Proceedings of the National Academy of Sciences Open access 7 Jan 2013 416
17 A Formalin-Inactivated Whole SIV Vaccine Confers Protection in Macaques Michael Murphey‐Corb, Louis N. Martin, B. Davison‐Fairburn et al. · Science 8 Dec 1989 407
18 G protein-coupled signal transduction pathways for interleukin-8 Ding Wen Wu, G J LaRosa, Melvin I. Simon · Science 2 Jul 1993 384
19 Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro Thomas J. Daly, Kathleen Sue Cook, Gary S. Gray et al. · Nature Dec 1989 382
20 Absence of B7-dependent responses in CD28-deficient mice Jonathan M. Green, Patricia J. Noel, Anne I. Sperling et al. · Immunity Sep 1994 382
21 Multiple biological activities of human recombinant interleukin 1. Charles Anthony Dinarello, Joseph G. Cannon, J W Mier et al. · Journal of Clinical Investigation Open access Jun 1986 369
22 Uncovering of Functional Alternative CTLA-4 Counter-Receptor in B7-Deficient Mice Gordon James Freeman, Frank Borriello, Richard J. Hodes et al. · Science 5 Nov 1993 366
23 Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1 Kashi Javaherian, A J Langlois, Greg J. LaRosa et al. · Science 14 Dec 1990 351
24 Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. Gordon James Freeman, G S Gray, Claude D. Gimmi et al. · The Journal of Experimental Medicine Open access Sep 1991 347
25 HTLV-III/LAV-Neutralizing Antibodies to an E. coli -Produced Fragment of the Virus Envelope Scott D. Putney, Thomas J. Matthews, W. Gerard Robey et al. · Science 12 Dec 1986 332
26 CTLA4 mediates antigen-specific apoptosis of human T cells. John G. Gribben, Gordon James Freeman, Vassiliki A. Boussiotis et al. · Proceedings of the National Academy of Sciences Open access 31 Jan 1995 326
27 Characterization of CTLA-4 structure and expression on human T cells. Tullia Lindsten, K P Lee, Estelle S. Harris et al. · The Journal of Immunology Oct 1993 323
28 Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. Deborah J. Lenschow, Anne I. Sperling, Michael P. Cooke et al. · The Journal of Immunology Sep 1994 292
29 Defining the Interleukin-8-binding Domain of Heparan Sulfate Dorothe Spillmann, Dan Witt, Ulf Lindahl · Journal of Biological Chemistry Open access Jun 1998 269
30 Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures Nikita Kotlov et al. · Cancer Discovery Open access 4 Feb 2021 266
31 C5L2, a Nonsignaling C5A Binding Protein Shoji Okinaga, Dubhfeasa Slattery, Alison A. Humbles et al. · Biochemistry 15 Jul 2003 263
32 A Leucine Zipper Stabilizes the Pentameric Membrane Domain of Phospholamban and Forms a Coiled-coil Pore Structure Heather K.B. Simmerman, Yvonne Monique Kobayashi, Joseph M. Autry et al. · Journal of Biological Chemistry Open access Mar 1996 257
33 Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. Gilbert L. Kukielka, C. Wayne Smith, G J LaRosa et al. · Journal of Clinical Investigation Open access 1995 246
34 Crystal Structure of the Principal Neutralization Site of HIV-1 Jayant B. Ghiara, Enrico Adriano Stura, Robyn L. Stanfield et al. · Science Apr 1994 242
35 Anti‐CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat H. Chen, Michael Chopp, R. L. Zhang et al. · Annals of Neurology Apr 1994 230
36 Physical and enzymatic properties of lignin peroxidase isoenzymes from Phanerochaete chrysosporium Roberta L. Farrell, Karen E. Murtagh, Ming Tien et al. · Enzyme and Microbial Technology Jun 1989 215
37 Use of Micropatterned Cocultures to Detect Compounds That Cause Drug-Induced Liver Injury in Humans Salman R. Khetani, Chitra Kanchagar, Okechukwu T. Ukairo et al. · Toxicological Sciences 14 Nov 2012 211
38 Major antigen-induced domain rearrangements in an antibody Robyn L. Stanfield, Midori Takimoto‐Kamimura, James M. Rini et al. · Structure Oct 1993 209
39 Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Vassiliki A. Boussiotis, Gordon James Freeman, JG Gribben et al. · Proceedings of the National Academy of Sciences Open access Dec 1993 206
40 Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent Mechanisms Stela Gengrinovitch, Sheryl M. Greenberg, Tzafra Cohen et al. · Journal of Biological Chemistry Open access Jun 1995 200
41 Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. Michael K. Racke, Dorothy E. Scott, Laura Quigley et al. · Journal of Clinical Investigation Open access Nov 1995 192
42 Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4 Richard J. Sharpe, H. Randolph Byers, Charles F. Scott et al. · JNCI Journal of the National Cancer Institute Open access 16 May 1990 192
43 A Single Amino Acid Interchange Yields Reciprocal CTL Specificities for HIV-1 gp160 Hidemi Takahashi, Silvia Merli, Scott D. Putney et al. · Science 6 Oct 1989 178
44 Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. G J LaRosa, Kaden M. Thomas, Maren Kaufmann et al. · Journal of Biological Chemistry Open access Dec 1992 175
45 Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease Haiqun Jia, Judit Pallos, Vincent Jacques et al. · Neurobiology of Disease Open access 12 Feb 2012 166
46 INHIBITION OF TRANSPLANT REJECTION FOLLOWING TREATMENT WITH ANTI-B7-2 AND ANTI-B7-1 ANTIBODIES Deborah J. Lenschow, Yijun Zeng, Karen S. Hathcock et al. · Transplantation Nov 1995 162
47 Epigenetic therapy for F riedreich ataxia Elisabetta Soragni et al. · Annals of Neurology Open access 27 Aug 2014 155
48 Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac Tom S. Chan, Hongbin Yu, Amanda Moore et al. · Drug Metabolism and Disposition 20 Aug 2013 151
49 Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. Peter James Perrin, Dorothy E. Scott, Laura Quigley et al. · The Journal of Immunology Feb 1995 149
50 Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. T E Maione, G S Gray, Anthony J. Hunt et al. · PubMed 15 Apr 1991 148

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.